Alvotech Entered into an Exclusive License Agreement with Kashiv BioSciences to Develop and Commercialize AVT23, a Proposed Biosim...
October 4, 2023
Fuji Pharma Receives the MHLW Approval of AVT04 (biosimilar, ustekinumab) in Japan
September 25, 2023
Alvotech and Bioventure Receives Approval of AVT02 (biosimilar, adalimumab) from Egyptian Drug Authority in Egypt
August 29, 2023
Alvotech Highlighted 52wk. Study Results of AVT04 (biosimilar, ustekinumab) for Chronic Plaque Psoriasis
August 18, 2023
Alvotech Receives Complete Response Letter on Second BLA for AVT02
June 28, 2023
Alvotech and Teva Settled with Johnson & Johnson for AVT04, a Proposed Biosimilar to Stelara (ustekinumab)
June 12, 2023
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.